TerrAscend (TSNDF) Total Current Liabilities (2021 - 2026)

TerrAscend's (TSNDF) quarterly Total Current Liabilities came in at $67.7 million in Q1 2026, down 12.43% year-on-year from $77.3 million in Q1 2025, and down 15.33% on a QoQ basis from $79.9 million in Q4 2025.

TerrAscend (TSNDF) Total Current Liabilities (2021 - 2026) Analysis & Trends

TerrAscend (TSNDF) has 6 years of Total Current Liabilities data on file, last reported at $67.7 million in Q1 2026.

  • On a quarterly basis, Total Current Liabilities fell 12.43% year-over-year to $67.7 million in Q1 2026; TTM through Mar 2026 was $67.7 million, a 12.43% decrease from a year earlier, with the FY2025 full-year figure at $79.9 million, down 12.21% from the prior year.
  • Total Current Liabilities for Q1 2026 stood at $67.7 million, down from $79.9 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for TSNDF reached as high as $207.0 million in Q4 2023 and fell as low as $67.7 million in Q1 2026.
  • Historically, Total Current Liabilities has averaged $122.4 million across 5 years, with a median of $133.5 million in 2023.
  • Across the five-year window, Total Current Liabilities jumped 108.36% in 2022 and plunged 61.18% in 2025, its largest moves.
  • Year by year, Total Current Liabilities stood at $137.9 million in 2022, then soared by 50.1% to $207.0 million in 2023, then sank by 56.01% to $91.0 million in 2024, then retreated by 12.21% to $79.9 million in 2025, then slipped by 15.33% to $67.7 million in 2026.
  • Per Business Quant data, the three most recent Total Current Liabilities figures were $67.7 million in Q1 2026, $79.9 million in Q4 2025, and $76.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 6.56 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 13.53 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 2.05 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 18.06 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 599.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 13.17 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 6.81 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 831.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 1.66 Bn
10 TerrAscend 160.44 Mn 162.98 Mn 34.60 Mn 67.68 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 67.68 Mn
Dec 31, 2025 79.93 Mn
Sep 30, 2025 76.31 Mn
Jun 30, 2025 91.66 Mn
Mar 31, 2025 77.29 Mn
Dec 31, 2024 91.05 Mn
Sep 30, 2024 78.46 Mn
Jun 30, 2024 77.46 Mn
Mar 31, 2024 199.12 Mn
Dec 31, 2023 207.00 Mn
Sep 30, 2023 146.38 Mn
Jun 30, 2023 133.49 Mn
Mar 31, 2023 156.07 Mn
Dec 31, 2022 137.91 Mn
Sep 30, 2022 172.34 Mn
Jun 30, 2022 140.40 Mn
Mar 31, 2022 148.27 Mn
Dec 31, 2021 66.19 Mn